Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients

MR Skanning Med Leverspecifikt Oralt Kontraststof Sammenlignet Med CT Skanning Hos Colorectalcancer Patienter Med Levermetastaser

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00718055

Enrollment

Registered

2008-07-18

Start date

2006-11-30

Completion date

Unknown

Last updated

2009-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Neoplasms, Contrast Media, Liver, Magnetic Resonance Imaging, Neoplasm Metastasis

Keywords

MRI, liverspecific, contrast, colorectal, metastases

Brief summary

The purpose of this study is to determine whether MRI with manganese containing contrast agent detects more livermetastasis compared to CT scan

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* biopsy proved liver metastasis

Exclusion criteria

* pacemaker, metal in the body, claustrophobia, pregnancy, age below 18 years, psychiatry patients

Countries

Denmark

Outcome results